WHO halts trial of hydroxychloroquine in COVID-19 patients

Boxes of Hydroxychloroquine are seen at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege

GENEVA/LONDON (Reuters) - The World Health Organization said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit.

"The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.


(Reporting by Mike Shields, Emma Farge and Kate Kelland, editing by Peter Graff and Kevin Liffey)